Assembly Biosciences, Inc.
ASMB
$32.87
-$2.41-6.83%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 38.94% | -12.80% | 477.26% | 57.62% | 12.81% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 38.94% | -12.80% | 477.26% | 57.62% | 12.81% |
| Cost of Revenue | -7.49% | 0.33% | 20.80% | 22.73% | -0.82% |
| Gross Profit | 76.26% | -23.10% | 464.28% | 13.07% | 15.88% |
| SG&A Expenses | 4.51% | 3.86% | 17.60% | 18.64% | 2.61% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -4.83% | 1.15% | 20.02% | 21.75% | -0.08% |
| Operating Income | 42.81% | -14.37% | 271.69% | 0.67% | 9.10% |
| Income Before Tax | 62.18% | -2.96% | 312.18% | 4.34% | 5.10% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 62.18% | -2.96% | 313.74% | 4.34% | 8.55% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 62.18% | -2.96% | 313.74% | 4.34% | 8.55% |
| EBIT | 42.81% | -14.37% | 271.69% | 0.67% | 9.10% |
| EBITDA | 42.83% | -14.49% | 272.44% | 0.66% | 9.12% |
| EPS Basic | 84.64% | 54.27% | 182.46% | 52.10% | 32.60% |
| Normalized Basic EPS | 84.64% | 54.26% | 181.86% | 52.10% | 30.05% |
| EPS Diluted | 84.64% | 54.27% | 182.46% | 52.10% | 32.60% |
| Normalized Diluted EPS | 84.64% | 54.26% | 181.86% | 52.10% | 30.05% |
| Average Basic Shares Outstanding | 146.26% | 125.15% | 159.20% | 99.74% | 35.68% |
| Average Diluted Shares Outstanding | 146.26% | 125.15% | 159.20% | 99.74% | 35.68% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |